Dexamethasone /kg
PreclinicalSmall molecule
Dexamethasone /kg is one of 13 small molecule programs targeting Cellulitis. It is currently in Preclinical.
1
Indications
5
Total Trials
2
Active Trials
12
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
17 competitors in Cellulitis
#DrugCompanyPhaseTrials
1Acanya
PfizerApproved
Avelox
BayerApproved
Cubicin
BBaxter Healthcare Corporation
Approved
Vancocin
HHikma Pharmaceuticals LLC
Approved
Levaquin
WWim Janssens
Approved
Ancef
BBaxter Healthcare Corporation
Approved
Flucloxacillin
AbbVieApproved
Phenoxymethylpenicillin
UUniversity of Aarhus
Approved
Keflex
Eli LillyPreclinical
Rayos
RRoxane Laboratories
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Cellulitis1 trial
Post Spinal Anesthesia Shivering1 trial
The Effect of Different Doses of Dexamethasone on Post Spinal Anesthesia Shivering
Not yet recruiting·—·N/A·NCT06999070·150 enrolled
Multimodal Analgesia1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Dexamethasone /kg. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- NNorthwestern University